Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.
Kong HK, Park SJ, Kim YS, Kim KM, Lee HW, Kang HG, Woo YM, Park EY, Ko JY, Suzuki H, Chun KH, Song E, Jang KY, Park JH.
Kong HK, et al. Among authors: kim km, kim ys.
Oncotarget. 2016 Aug 23;7(34):55677-55689. doi: 10.18632/oncotarget.10972.
Oncotarget. 2016.
PMID: 27494879
Free PMC article.